Octagon Capital Advisors’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-122,800
| Closed | -$325K | – | 39 |
|
|
2022
Q2 | $325K | Sell |
122,800
-26,600
| -18% | -$70.4K | 0.09% | 20 |
|
|
2022
Q1 | $616K | Sell |
149,400
-187,468
| -56% | -$773K | 0.13% | 24 |
|
|
2021
Q4 | $3.04M | Sell |
336,868
-13,132
| -4% | -$119K | 0.59% | 23 |
|
|
2021
Q3 | $4.73M | Sell |
350,000
-100,000
| -22% | -$1.35M | 1.16% | 20 |
|
|
2021
Q2 | $8.82M | Buy |
+450,000
| New | +$8.82M | 1.83% | 17 |
|